HALOZYME THERAPEUTICS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for HALOZYME THERAPEUTICS INC NOTE 1.250%12/0, CUSIP 40637HAB5.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for HALOZYME THERAPEUTICS INC NOTE 1.250%12/0, CUSIP 40637HAB5.